Patient Guide: Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 126 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04241185
Status: ACTIVE_NOT_RECRUITING
Condition: Urinary Bladder Neoplasms
Phase: PHASE3

Find a Study Location Near You

This study is available at 126 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Washington, District of Columbia
  • Bay Pines, Florida
  • Orlando, Florida
  • • And 123 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily